Structure Therapeutics Inc. Earnings Per Share (Basic)
Structure Therapeutics Inc. (GPCR) reported Earnings Per Share (Basic) of -$0.49 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Structure Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.49.
- Structure Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.35.
- Structure Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.37.
- Structure Therapeutics Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.36.
- Structure Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$0.80.
- Structure Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$0.78.
- Structure Therapeutics Inc. earnings per share, basic for fiscal 2023 was -$0.81.
- Structure Therapeutics Inc. earnings per share, basic for fiscal 2022 was -$5.51.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.49 10-Q · filed 2026-08-06 | -$0.84 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$0.35 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$0.80 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$0.37 10-Q · filed 2025-11-06 | -$1.00 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$0.36 10-Q · filed 2026-08-06 | -$0.63 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | -$0.27 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$0.78 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$0.20 10-Q · filed 2025-11-06 | -$0.38 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.56 10-Q · filed 2025-11-06 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-06-30 | -$0.18 10-Q · filed 2025-08-06 | -$0.36 10-Q · filed 2025-08-06 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-03-31 | -$0.19 10-Q · filed 2025-05-08 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2023-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.81 10-K · filed 2026-02-26 |
| 2023-09-30 | -$0.21 10-Q · filed 2024-11-13 | -$0.41 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.65 10-Q · filed 2024-11-13 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2023-06-30 | -$0.20 10-Q · filed 2024-08-08 | -$0.44 10-Q · filed 2024-08-08 | -$0.81 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$1.27 derived: net income ÷ weighted average shares · filed 2024-08-08 |
| 2023-03-31 | -$0.25 10-Q · filed 2024-05-09 | -$0.73 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$1.39 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$2.29 derived: net income ÷ weighted average shares · filed 2024-05-09 |
| 2022-12-31 | -$1.18 derived: net income ÷ weighted average shares · filed 2024-03-08 | -$2.45 derived: net income ÷ weighted average shares · filed 2024-03-08 | -$4.08 derived: net income ÷ weighted average shares · filed 2024-03-08 | -$5.51 10-K · filed 2024-03-08 |
| 2022-09-30 | -$1.27 10-Q · filed 2023-11-17 | -$2.90 derived: net income ÷ weighted average shares · filed 2023-11-17 | -$4.34 10-Q · filed 2023-11-17 | |
| 2022-06-30 | -$1.64 10-Q/A · filed 2023-11-17 | -$3.09 10-Q/A · filed 2023-11-17 | ||
| 2022-03-31 | -$1.44 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |